20
Participants
Start Date
November 16, 2021
Primary Completion Date
November 22, 2021
Study Completion Date
January 12, 2022
KX01 ointment 1%
A total of 4 application sites (2 cm x 2 cm each) will be marked on each subject's back, placing 2 sites for KX01 ointment 1% and 2 sites for Placebo ointment. One set (KX01 ointment 1% and Placebo ointment patches) will be designated for irradiation and the other set will remain non-irradiated under open conditions.
Placebo ointment
A total of 4 application sites (2 cm x 2 cm each) will be marked on each subject's back, placing 2 sites for KX01 ointment 1% and 2 sites for Placebo ointment. One set (KX01 ointment 1% and Placebo ointment patches) will be designated for irradiation and the other set will remain non-irradiated under open conditions.
Medical Corporation HOUEIKAI, Sekino Clinical Pharmacology Clinic, Toshima-ku
Lead Sponsor
Collaborators (1)
PharmaEssentia Japan K.K.
INDUSTRY
PharmaEssentia
INDUSTRY